Assessment Ayurveda Drug Shadbindu Taila as Nasal drop, Trayodashanga Guggulu tab as oral medication and Physio Therapy In The Management Of Cervical Spondylosis and Anti Inflammatory Effect Of Nasya - A Randomized Controlled Clinical Study

Phase 2

Not yet recruiting

• Conditions: Other spondylosis with radiculopathy,

• Registration Number: CTRI/2020/06/025538
• Lead Sponsor: Institute for Post Graduate Training and Research in Ayurveda

Brief Summary

This study is a comparative clinical trial to assess  shadbindu taila nasya trayodashanga guggulu and physiotherapy in the management of cervical spondylosis and anti inflammatory effect of nasya also

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-06
• Last Update Posted: 2020-05-14

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Diagnosed cases of cervical spondylosis Participants of age group between 18 to 65 years, belonging to either of the sex Participants indicated for nasya karma Willing to sign the consent for study participation.

Exclusion Criteria

Uncontrolled diabetes mellitus, hypertension and other systemic illness Ankylosing spondylitis, adhesive capsulitis etc Anemia (hemoglobin % <07.00 mg/dl) Pregnancy Participants contraindicated for nasya.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relief in signs and symptoms of cervical spondylosis	within 2 years of time

Secondary Outcome Measures

Name	Time	Method
Improvement in quality of life and social well being of participant	Within 2years from trial

Trial Locations

Locations (1)

PG Hospital Institute for Post Graduate Training and Research in Ayurveda; 🇮🇳 Jamnagar, GUJARAT, India

PG Hospital Institute for Post Graduate Training and Research in Ayurveda

🇮🇳Jamnagar, GUJARAT, India

Sreekala A P

Principal investigator

9526084065

drsreeekuty@gmail.com